Parenteral Drugs (India) Ltd

PDPL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹12 cr, stock is ranked 3,186
High RiskStock is 6.85x as volatile as Nifty
4.300.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹12 cr, stock is ranked 3,186
High RiskStock is 6.85x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-0.11
PB RatioPB Ratio
-0.02
Dividend YieldDiv. Yield
Sector PESector PE
38.20
Sector PBSector PB
5.09
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021225.5133.4532.1212.23-111.79-147.90-114.09-121.72
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Resignation 
Announced OnNov 30, 2021

Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mrs Deepali Garehwal as Non- Executive Independent Director of the company w.e.f. November 30, 2021. | Download

Parenteral Drugs (India) Limited has informed the Exchange regarding Resignation of Mrs Deepali Garehwal as Non- Executive Independent Director of the company w.e.f. November 30, 2021. | Download

Copy of Newspaper Publication 
Announced OnNov 15, 2021

Parenteral Drugs (India) Limited has informed the Exchange regarding publication of Unaudited Financial results for the Quarter and half year ended on 30th September, 2021 in newspaper | Download

Parenteral Drugs (India) Limited has informed the Exchange regarding publication of Unaudited Financial results for the Quarter and half year ended on 30th September, 2021 in newspaper | Download

Financial Result Updates 
Announced OnNov 12, 2021

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021. | Download

See all events